Mohammed Sika

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. ncbi Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study
    Mohammed Sika
    Medicine, Vanderbilt, Nashville, TN, USA
    Am J Kidney Dis 50:78-89, 89.e1. 2007
  2. ncbi Blood pressure control, drug therapy, and kidney disease
    Gabriel Contreras
    University of Miami, Miami, FL, USA
    Hypertension 46:44-50. 2005
  3. ncbi Quality of life in the African American Study of Kidney Disease and Hypertension: effects of blood pressure management
    James P Lash
    University of Illinois, Chicago, IL 60612 7315, USA
    Am J Kidney Dis 47:956-64. 2006
  4. ncbi Predictors of participant adherence and retention in the African American Study of Kidney Disease and Hypertension
    Deborah Brooks
    Medical University of South Carolina, Charleston, SC, USA
    Nephrol Nurs J 35:133-42. 2008
  5. ncbi Validation of creatinine-based estimates of GFR when evaluating risk factors in longitudinal studies of kidney disease
    Xuelei Wang
    Cleveland Clinic Foundation, Department of Quantitative Health Sciences, Wb 4, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Am Soc Nephrol 17:2900-9. 2006
  6. ncbi A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease
    Marvin Sinsakul
    Rush University Medical Center, Chicago, IL 60607, USA
    Am J Kidney Dis 50:946-51. 2007

Collaborators

Detail Information

Publications6

  1. ncbi Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study
    Mohammed Sika
    Medicine, Vanderbilt, Nashville, TN, USA
    Am J Kidney Dis 50:78-89, 89.e1. 2007
    ....
  2. ncbi Blood pressure control, drug therapy, and kidney disease
    Gabriel Contreras
    University of Miami, Miami, FL, USA
    Hypertension 46:44-50. 2005
    ..These secondary analyses suggest a benefit of the low BP goal among patients assigned to amlodipine, but they must be interpreted cautiously...
  3. ncbi Quality of life in the African American Study of Kidney Disease and Hypertension: effects of blood pressure management
    James P Lash
    University of Illinois, Chicago, IL 60612 7315, USA
    Am J Kidney Dis 47:956-64. 2006
    ..We examined effects of treatment-group assignment on health-related quality of life (HRQOL) measures and reported symptoms during 4 years of follow-up...
  4. ncbi Predictors of participant adherence and retention in the African American Study of Kidney Disease and Hypertension
    Deborah Brooks
    Medical University of South Carolina, Charleston, SC, USA
    Nephrol Nurs J 35:133-42. 2008
    ....
  5. ncbi Validation of creatinine-based estimates of GFR when evaluating risk factors in longitudinal studies of kidney disease
    Xuelei Wang
    Cleveland Clinic Foundation, Department of Quantitative Health Sciences, Wb 4, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Am Soc Nephrol 17:2900-9. 2006
    ....
  6. ncbi A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease
    Marvin Sinsakul
    Rush University Medical Center, Chicago, IL 60607, USA
    Am J Kidney Dis 50:946-51. 2007
    ..The objective of this study is to compare the efficacy and safety of celecoxib with placebo for decreasing proteinuria in patients with diabetic nephropathy...